These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23890693)

  • 81. [Behavior of the chemiluminescent ELISA method in relation to results considered discordant via three conventional techniques for diagnosing Chagas disease].
    De Marchi CR; Amato Neto V; de Almeida IC
    Rev Soc Bras Med Trop; 2007; 40(1):68-70. PubMed ID: 17486258
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Congenital chagas disease: Development and assessment of a specific IgM capture-based assay for diagnosis of transmission.
    Peverengo LM; Rodeles LM; Maldonado C; Ballering G; Pujato N; D'Amico I; Vicco MH; Garcia L; Jurado L; Altcheh J; Marcipar I
    Acta Trop; 2021 Jan; 213():105738. PubMed ID: 33159901
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Evaluation of a chemiluminescent enzyme-linked immunosorbent assay for the diagnosis of Trypanosoma cruzi infection in a nonendemic setting.
    Izquierdo L; Marques AF; Gállego M; Sanz S; Tebar S; Riera C; Quintó L; Aldasoro E; Almeida IC; Gascon J
    Mem Inst Oswaldo Cruz; 2013 Nov; 108(7):928-31. PubMed ID: 24271047
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Evaluation of the "Symbiosys" immunoassay for the serological diagnosis of Chagas disease.
    Souza RM; Amato Neto V; Bezerra RC; Gakyia E; Braz LM
    Rev Inst Med Trop Sao Paulo; 2012; 54(2):115-6. PubMed ID: 22499427
    [No Abstract]   [Full Text] [Related]  

  • 85. Describing nearly two decades of Chagas disease in Germany and the lessons learned: a retrospective study on screening, detection, diagnosis, and treatment of Trypanosoma cruzi infection from 2000 - 2018.
    Guggenbühl Noller JM; Froeschl G; Eisermann P; Jochum J; Theuring S; Reiter-Owona I; Bissinger AL; Hoelscher M; Bakuli A; von Sonnenburg FF; Rothe C; Bretzel G; Albajar-Viñas P; Grout L; Pritsch M
    BMC Infect Dis; 2020 Dec; 20(1):919. PubMed ID: 33272201
    [TBL] [Abstract][Full Text] [Related]  

  • 86. First report of family clusters of Chagas disease seropositive blood donors in Mexico City and their epidemiological relevance.
    Espinoza B; Martínez I; Schabib-Hany M
    Acta Trop; 2019 May; 193():23-30. PubMed ID: 30771283
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Western blot technique standardization for specific diagnosis of Chagas disease using excretory-secretory antigens of Trypanosoma cruzi epimastigotes].
    Escalante H; Jara C; Davelois K; Iglesias M; Benites A; Espinoza R
    Rev Peru Med Exp Salud Publica; 2014; 31(4):644-51. PubMed ID: 25597713
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Specificity of the intradermal Montenegro test in patients infected by Trypanosoma cruzi from different regions of Peru].
    Minaya-Gómez G; Vargas-Apaza S; Monteza-Zuloeta Y; Purisaca-Morante E; Delgado-Diaz F
    Rev Peru Med Exp Salud Publica; 2014 Apr; 31(2):278-81. PubMed ID: 25123866
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Disagreement between PCR and serological diagnosis of Trypanosoma cruzi infection in blood donors from a Colombian endemic region.
    García Sánchez LT; Aguilar Jiménez JR; Bueno MY; Moreno Moreno EM; Ramírez H; Daza N
    Biomedica; 2021 May; 41(Supl. 1):47-59. PubMed ID: 34111340
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Evaluation of UMELISA CHAGAS™ with the incorporation of new monomeric and chimeric peptides representative of different regions of Trypanosoma cruzi.
    Hernández I; Hernández M; González J; Gómez I; Zulueta O; Ramos G; Ortega D; Bequer DC; Martínez GE; Delahanty A
    Biomedica; 2021 May; 41(Supl. 1):113-120. PubMed ID: 34111344
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A Multi-Epitope Protein for High-Performance Serodiagnosis of Chronic Chagas Disease in ELISA and Lateral Flow Platforms.
    Dias ER; Durans AM; Succar BB; Pinto LALT; Lechuga GC; Miguez MG; Figueira-Mansur J; Argondizzo APC; Bernardo AR; Diniz RL; Esteves GS; Silva ED; Morel CM; Borges-Pereira J; De-Simone SG; Junqueira ACV; Provance DW
    Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337297
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Discrepancies and consequences of indirect hemagglutination, indirect immunofluorescence and ELISA tests for the diagnosis of Chagas disease.
    Souza RM; Amato Neto V
    Rev Inst Med Trop Sao Paulo; 2012; 54(3):141-3. PubMed ID: 22634885
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Differential serodiagnosis of human infections caused by Trypanosoma cruzi and Leishmania spp. using ELISA with a recombinant antigen (rTc24).
    Passos VM; Volpini AC; Braga EM; Lacerda PA; Ouaissi A; Lima-Martins MV; Krettli AU
    Mem Inst Oswaldo Cruz; 1997; 92(6):791-3. PubMed ID: 9566210
    [No Abstract]   [Full Text] [Related]  

  • 94. Evaluation of the Performance of Ortho T. cruzi ELISA Test System for the Detection of Antibodies to Trypanosoma cruzi.
    Rivera HN; McAuliffe I; Aderohunmu T; Wiegand RE; Montgomery SP; Bradbury RS; Handali S
    J Clin Microbiol; 2022 Aug; 60(8):e0013422. PubMed ID: 35862752
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Comparison of seven diagnostic tests to detect Trypanosoma cruzi infection in patients in chronic phase of Chagas disease.
    Duarte LF; Flórez O; Rincón G; González CI
    Colomb Med (Cali); 2014; 45(2):61-6. PubMed ID: 25100890
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Field evaluation of a rapid immunochromatographic assay for detection of Trypanosoma cruzi infection by use of whole blood.
    Roddy P; Goiri J; Flevaud L; Palma PP; Morote S; Lima N; Villa L; Torrico F; Albajar-Viñas P
    J Clin Microbiol; 2008 Jun; 46(6):2022-7. PubMed ID: 18400910
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Comparative evaluation of 11 commercialized rapid diagnostic tests for detecting Trypanosoma cruzi antibodies in serum banks in areas of endemicity and nonendemicity.
    Sánchez-Camargo CL; Albajar-Viñas P; Wilkins PP; Nieto J; Leiby DA; Paris L; Scollo K; Flórez C; Guzmán-Bracho C; Luquetti AO; Calvo N; Tadokoro K; Saez-Alquezar A; Palma PP; Martin M; Flevaud L
    J Clin Microbiol; 2014 Jul; 52(7):2506-12. PubMed ID: 24808239
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Pfizer-BioNTech vaccine induces the production of cross-reactive antibodies against Trypanosoma cruzi proteins: A preliminary study.
    López-Monteon A; Balderas-Caballero AE; Domínguez-Guillén JA; Romero-Ramírez H; Baltierra-Uribe SL; Ramos-Ligonio A
    Trop Med Int Health; 2023 May; 28(5):384-390. PubMed ID: 36879355
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Antibodies to Trypanosoma cruzi among blood donors in Buenos Aires, Argentina.
    Blejer JL; Saguier MC; Salamone HJ
    Int J Infect Dis; 2001; 5(2):89-93. PubMed ID: 11468104
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Chagas' disease screening in blood bank employing enzyme immunoassay.
    Knecher LM; Rojkín LF; Capriotti GA; Lorenzo LE
    Int J Parasitol; 1994 Apr; 24(2):207-11. PubMed ID: 8026897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.